Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Becton Dickinson and Co (NYSE:BDX)

166.99
Delayed Data
As of May 27
 -0.20 / -0.12%
Today’s Change
128.87
Today|||52-Week Range
169.08
+8.37%
Year-to-Date
3 Stocks I Was Glad to Sell Recently
May 17 / MotleyFool.com - Paid Partner Content
Becton, Dickinson's (BDX) MAX Vaginal Panel Gets CE Mark
May 16 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close167.19
Today’s open167.07
Day’s range166.40 - 167.38
Volume648,605
Average volume (3 months)1,073,311
Market cap$35.5B
Dividend yield1.58%
Data as of 4:00pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-44.07%
Earnings growth (this year)+19.59%
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)+21.94%
P/E ratio44.7
Price/Sales2.68
Price/Book4.92

Competitors

 Today’s
change
Today’s
% change
BSXBoston Scientific Co...+0.02+0.09%
SYKStryker Corp+0.19+0.17%
ZBHZimmer Biomet Holdin...+0.58+0.47%
EWEdwards Lifesciences...+0.61+0.61%
Data as of 4:04pm ET, 05/27/2016

Financials

Next reporting dateJuly 28, 2016
EPS forecast (this quarter)$2.21
Annual revenue (last year)$10.3B
Annual profit (last year)$695.0M
Net profit margin6.76%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Vincent A. Forlenza
Chief Financial Officer &
EVP-Administration
Christopher R. Reidy
Corporate headquarters
Franklin Lakes, New Jersey

Forecasts

Partner Offers

Search for Jobs